SEARCH

SEARCH BY CITATION

References

  • Andreoli, M., Tessari, M., Pilla, M., Valerio, E., Hagan, J. J. & Heidbreder, C. A. (2003) Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28, 12721280.
  • Balfour, D. J. (2009) The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb Exp Pharmacol 192, 209233.
  • Balfour, D. J., Wright, A. E., Benwell, M. E. & Birrell, C. E. (2000) The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113, 7383.
  • Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263265.
  • Bouthenet, M. L., Souil, E., Martres, M. P., Sokoloff, P., Giros, B. & Schwartz, J. C. (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564, 203219.
  • Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Scheibal, D., Hahn, E., Shiraga, S., Zamora-Paja, E., Farahi, J., Saxena, S., London, E. D. & McCracken, J. T. (2006) Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63, 808816.
  • Comings, D. E., Gade, R., Wu, S., Chiu, C., Dietz, G., Muhleman, D., Saucier, G., Ferry, L., Rosenthal, R. J., Lesieur, H. R., Rugle, L. J. & MacMurray, P. (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2, 4456.
  • Corrigall, W. A., Franklin, K. B., Coen, K. M. & Clarke, P. B. (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285289.
  • Dalack, G. W., Healy, D. J. & Meador-Woodruff, J. H. (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155, 14901501.
  • David, V., Besson, M., Changeux, J. P., Granon, S. & Cazala, P. (2006) Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50, 10301040.
  • Dudbridge, F. (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25, 115121.
  • Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. & Weinberger D. R. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257269.
  • Enoch, M. A., Xu, K., Hodgkinson, C., Shen, P. H., Yuan, Q. & Goldman, D. (2006) Candidate Gene Association Studies Using an Addictions Microarray. Paper presented at the ISBRA 2006 World Congress on Alcohol Research from http://www.isbra2006.com/abstract/112.htm
  • Gauderman, W. J. & Morrison, J. M. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. [http://hydra.usc.edu/gxe]. 2006.
  • Graham, D. L., Edwards, S., Bachtell, R. K., DiLeone, R. J., Rios, M. & Self, D. W. (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10, 10291037.
  • Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C. & Sokoloff, P. (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 8689.
  • Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F. & Weinberger DR. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 66906694.
  • Huang, W., Payne, T. J., Ma, J. Z. & Li, M. D. (2008a) A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet Part B, Neuropsych Genet 147B, 11091115.
  • Huang, W., Ma, J. Z., Payne, T. J., Beuten, J., Dupont, R. T. & Li, M. D. (2008b) Significant association of DRD1 with nicotine dependence. Hum Genet 123, 133140.
  • Jeanneteau, F., Funalot, B., Jankovic, J., Deng, H., Lagarde, J. P., Lucotte, G. & Sokoloff, P. (2006) Proc Natl Acad Sci U S A 103, 1075310758.
  • Kenny, P. J., File, S. E. & Rattray, M. (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85, 234238.
  • Khaled, M. A., Farid Araki, K., Li, B., Coen, K. M., Marinelli, P. W., Varga, J., Gaál, J. & Le Foll, B. (2010) The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int J Neuropsychopharmacol 13, 181190.
  • Lang, U. E., Sander, T., Lohoff, F. W., Hellweg, R., Bajbouj, M., Winterer, G. & Gallinat, J. (2007) Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology 190, 433439.
  • Le Foll, B., Francès, H., Diaz, J., Schwartz, J. C. & Sokoloff, P. (2002) Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 15, 20162026.
  • Le Foll, B., Diaz, J. & Sokoloff, P. (2003a) Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47, 176183.
  • Le Foll, B., Schwartz, J. C. & Sokoloff, P. (2003b) Disruption of nicotine conditioning by dopamine D(3) receptor ligands. Mol Psychiatry 8, 225230.
  • Le Foll, B., Sokoloff, P., Stark, H. & Goldberg, S. R. (2005a) Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30, 720730.
  • Le Foll, B., Diaz, J. & Sokoloff, P. (2005b) A single cocaine exposure increases BDNF and D3 receptor expressions:implications for drug-conditioning. Neuroreport 16, 175178.
  • Le Foll, B., Goldberg, S. R. & Sokoloff, P. (2007) Dopamine D3 receptor ligands for the treatment of tobacco dependence. Expert Opin Investig Drugs 16, 4557.
  • Le Foll, B., Gallo, A., Le Strat, Y., Lu, L. & Gorwood, P. (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20, 117.
  • Lieberman, J. A., Alvir, J., Geisler, S., Ramos-Lorenzi, J., Woerner, M., Novacenko, H., Cooper, T. & Kane, J. M. (1994) Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 11, 107118.
  • Lu, L., Grimm, J. W., Hope, B. T. & Shaham, Y. (2004) Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology 47 Supplement 1, 214226.
  • Lundstrom, K. & Turpin, M. P. (1996) Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun 225, 10681072.
  • Marcellino, D., Ferre, S., Casado, V., Cortes, A., Le Foll, B., Mazzola, C., Drago, F., Saur, O., Stark, H., Soriano, A., Barnes, C., Goldberg, S. R., Lluis, C., Fuxe, K. & Franco, R. (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 283, 2601626025.
  • Novak, G., Boukhadra, J., Shaikh, S. A., Kennedy, J. L. & Le Foll, B. (2009) Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: A preliminary study. World J Biol Psychiatry 10, 929935.
  • Nyholt, D. R. (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74, 765769.
  • Nyholt, D. R. (2005) Evaluation of Nyholt's procedure for multiple testing correction – author's reply. Hum Hered 60, 6162.
  • Ott, J. (1991) Analysis of Human Genetic Linkage, revised edition. Baltimore : John Hopkins University Press.
  • Pak, A. C., Ashby, C. R. Jr., Heidbreder, C. A., Pilla, M., Gilbert, J., Xi, Z. X. & Gardner E. L. (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9, 585602.
  • Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., Fuxe, K. & Changeux, J. P. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173177.
  • Pontieri, F. E., Tanda, G., Orzi, F. & Di Chiara, G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255257.
  • Purcell, S., Cherny, S. S. & Sham, P. C. (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19, 149150.
  • Rybakowski, J. K. (2008) BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 9, 15891593.
  • Schoenbaum, G., Stalnaker, T. A. & Shaham, Y. (2007) A role for BDNF in cocaine reward and relapse. Nat Neurosci 10, 935936.
  • Schwartz, J. C., Diaz, J., Bordet, R., Griffon, N., Perachon, S., Pilon, C., Ridray, S. & Sokoloff, P. (1998) Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Res Brain Res Rev 26, 236242.
  • Seeman, P. (2006) Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets 10, 515531.
  • Sokoloff, P., Giros, B., Martres, M. P., Bouthenet, M. L. & Schwartz, J. C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146151.
  • Sokoloff, P., Guillin, O., Diaz, J., Carroll, P. & Griffon, N. (2002) Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders. Neurotox Res 4, 671678.
  • Spina, L., Fenu, S., Longoni, R., Rivas, E. & Di Chiara, G. (2006) Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology 184, 447455.
  • Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C. & Lester, H. A. (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306, 10291032.
  • Wang, Z. R., Zhou, D. F., Cao, L. Y., Tan, Y. L., Zhang, X. Y., Li, J., Lu, L., Wu, G. Y., Kosten, T. A. & Kosten, T. R. (2007) Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr Res 97, 299301.
  • Zai, C. C., Manchia, M., De Luca, V., Tiwari, A. K., Zai, G., Strauss, J., Shaikh, S., King, N., Meltzer, H. Y., Lieberman, J. A., Le Foll, B. & Kennedy, J. L. Genetic study of BDNF, DRD3, and their interaction in schizophrenia and suicidal behaviour. J Psychiatr Res (submitted).
  • Zai, C. C., Romano-Silva, M. A., Hwang, R., Zai, G. C., Deluca, V., Müller, D. J., King, N., Voineskos, A. N., Meltzer, H. Y., Lieberman, J. A., Potkin, S. G., Remington, G. & Kennedy, J. L. (2008) Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia. Schiz Res 106, 248252.